Neumora Therapeutics

NMRA

Date	Type	Insider	Position	Ø-Price	Volume
8/21/2026	Sell	Aurora, Daljit Singh	Officer	$1.6	$66,380
8/20/2026	Sell	Aurora, Daljit Singh	Officer	$1.5	$203,587
8/19/2026	Sell	Aurora, Daljit Singh	Officer	$1.6	$101,917
8/18/2026	Sell	Aurora, Daljit Singh	Officer	$1.6	$109,623
8/17/2026	Sell	Aurora, Daljit Singh	Officer	$1.5	$220,135
2/17/2026	Sell	Milligan, Michael Lee	Officer	$3.6	$5,119
2/17/2026	Sell	Berns, Paul L.	Officer	$3.5	$34,459
2/17/2026	Sell	Pinto, Joshua	President	$3.5	$21,093
2/17/2026	Sell	Aurora, Daljit Singh	Officer	$3.6	$21,917
11/11/2025	Sell	Aurora, Daljit Singh	Officer	$2.7	$307,026
10/27/2025	Buy	Arch Venture Partners X, LLC	Ten Percent Owner	$2.6	$4,999,977
10/27/2025	Buy	Arch Venture Partners Xii, LLC	Ten Percent Owner	$2.6	$4,999,977
10/27/2025	Buy	Burow, Kristina	Director	$2.6	$4,999,977
2/18/2025	Sell	Pinto, Joshua	President	$1.7	$13,477
2/18/2025	Sell	Lenz, Robert A.	Head of R&D	$1.7	$9,383
2/18/2025	Sell	Aurora, Daljit Singh	Chief Strategy Officer	$1.7	$14,347
2/18/2025	Sell	Milligan, Michael Lee	Officer	$1.7	$3,351
2/18/2025	Sell	Berns, Paul L.	Officer	$1.7	$23,468
10/18/2024	Sell	Fust, Matthew K.	Director	$17.0	$239,319
10/17/2024	Sell	Fust, Matthew K.	Director	$17.0	$131,643
10/10/2024	Sell	Lenz, Robert A.	Head of R&D	$15.1	$124,603
10/9/2024	Sell	Lenz, Robert A.	Head of R&D	$15.0	$83,507
9/18/2024	Sell	Lenz, Robert A.	Head of R&D	$12.1	$129,091
9/17/2024	Sell	Lenz, Robert A.	Head of R&D	$11.8	$363,736
9/12/2024	Sell	Lenz, Robert A.	Head of R&D	$11.4	$376,665